Pharmacogenomic assessment of Mexican and Peruvian populations

Sharon Marsh, Cristi R. King, Derek J. Van Booven, Jane Y. Revollo, Robert H Gilman, Howard L. McLeod

Research output: Contribution to journalArticle

Abstract

Background: Clinically relevant polymorphisms often demonstrate population-specific allele frequencies. Central and South America remain largely uncategorized in the context of pharmacogenomics. Materials & methods: We assessed 15 polymorphisms from 12 genes (ABCB1 3435C>T, ABCG2 Q141K, CYP1B1∗3, CYP2C19∗2, CYP3A4∗1B, CYP3A5∗3C, ERCC1 N118N, ERCC2 K751Q, GSTP1 I105V, TPMT 238G>C, TPMT 460G>A, TPMT 719A>G, TYMS TSER, UGT1A1∗28 and UGT1A1 -3156G>A) in 81 Peruvian and 95 Mexican individuals. Results: Six polymorphism frequencies differed significantly between the two populations: ABCB1 3435C>T, CYP1B1∗3, GSTP1 I105V, TPMT 460G>A, UGT1A1∗28 and UGT1A1 -3156G>A. The pattern of observed allele frequencies for all polymorphisms could not be accurately estimated from any single previously studied population. Conclusion: This highlights the need to expand the scope of geographic data for use in pharmacogenomics studies.

Original languageEnglish (US)
Pages (from-to)441-448
Number of pages8
JournalPharmacogenomics
Volume16
Issue number5
DOIs
StatePublished - Apr 1 2015

Fingerprint

Pharmacogenetics
Gene Frequency
Population
Central America
South America
Genes

Keywords

  • Genotype
  • Hispanic
  • Mexico
  • Peru
  • Pharmacogenomics
  • Polymorphism
  • Population

ASJC Scopus subject areas

  • Pharmacology
  • Genetics
  • Molecular Medicine

Cite this

Marsh, S., King, C. R., Van Booven, D. J., Revollo, J. Y., Gilman, R. H., & McLeod, H. L. (2015). Pharmacogenomic assessment of Mexican and Peruvian populations. Pharmacogenomics, 16(5), 441-448. https://doi.org/10.2217/pgs.15.10

Pharmacogenomic assessment of Mexican and Peruvian populations. / Marsh, Sharon; King, Cristi R.; Van Booven, Derek J.; Revollo, Jane Y.; Gilman, Robert H; McLeod, Howard L.

In: Pharmacogenomics, Vol. 16, No. 5, 01.04.2015, p. 441-448.

Research output: Contribution to journalArticle

Marsh, S, King, CR, Van Booven, DJ, Revollo, JY, Gilman, RH & McLeod, HL 2015, 'Pharmacogenomic assessment of Mexican and Peruvian populations', Pharmacogenomics, vol. 16, no. 5, pp. 441-448. https://doi.org/10.2217/pgs.15.10
Marsh S, King CR, Van Booven DJ, Revollo JY, Gilman RH, McLeod HL. Pharmacogenomic assessment of Mexican and Peruvian populations. Pharmacogenomics. 2015 Apr 1;16(5):441-448. https://doi.org/10.2217/pgs.15.10
Marsh, Sharon ; King, Cristi R. ; Van Booven, Derek J. ; Revollo, Jane Y. ; Gilman, Robert H ; McLeod, Howard L. / Pharmacogenomic assessment of Mexican and Peruvian populations. In: Pharmacogenomics. 2015 ; Vol. 16, No. 5. pp. 441-448.
@article{8e44ea962fcf4d1b8b4511326d1ec441,
title = "Pharmacogenomic assessment of Mexican and Peruvian populations",
abstract = "Background: Clinically relevant polymorphisms often demonstrate population-specific allele frequencies. Central and South America remain largely uncategorized in the context of pharmacogenomics. Materials & methods: We assessed 15 polymorphisms from 12 genes (ABCB1 3435C>T, ABCG2 Q141K, CYP1B1∗3, CYP2C19∗2, CYP3A4∗1B, CYP3A5∗3C, ERCC1 N118N, ERCC2 K751Q, GSTP1 I105V, TPMT 238G>C, TPMT 460G>A, TPMT 719A>G, TYMS TSER, UGT1A1∗28 and UGT1A1 -3156G>A) in 81 Peruvian and 95 Mexican individuals. Results: Six polymorphism frequencies differed significantly between the two populations: ABCB1 3435C>T, CYP1B1∗3, GSTP1 I105V, TPMT 460G>A, UGT1A1∗28 and UGT1A1 -3156G>A. The pattern of observed allele frequencies for all polymorphisms could not be accurately estimated from any single previously studied population. Conclusion: This highlights the need to expand the scope of geographic data for use in pharmacogenomics studies.",
keywords = "Genotype, Hispanic, Mexico, Peru, Pharmacogenomics, Polymorphism, Population",
author = "Sharon Marsh and King, {Cristi R.} and {Van Booven}, {Derek J.} and Revollo, {Jane Y.} and Gilman, {Robert H} and McLeod, {Howard L.}",
year = "2015",
month = "4",
day = "1",
doi = "10.2217/pgs.15.10",
language = "English (US)",
volume = "16",
pages = "441--448",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "5",

}

TY - JOUR

T1 - Pharmacogenomic assessment of Mexican and Peruvian populations

AU - Marsh, Sharon

AU - King, Cristi R.

AU - Van Booven, Derek J.

AU - Revollo, Jane Y.

AU - Gilman, Robert H

AU - McLeod, Howard L.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Background: Clinically relevant polymorphisms often demonstrate population-specific allele frequencies. Central and South America remain largely uncategorized in the context of pharmacogenomics. Materials & methods: We assessed 15 polymorphisms from 12 genes (ABCB1 3435C>T, ABCG2 Q141K, CYP1B1∗3, CYP2C19∗2, CYP3A4∗1B, CYP3A5∗3C, ERCC1 N118N, ERCC2 K751Q, GSTP1 I105V, TPMT 238G>C, TPMT 460G>A, TPMT 719A>G, TYMS TSER, UGT1A1∗28 and UGT1A1 -3156G>A) in 81 Peruvian and 95 Mexican individuals. Results: Six polymorphism frequencies differed significantly between the two populations: ABCB1 3435C>T, CYP1B1∗3, GSTP1 I105V, TPMT 460G>A, UGT1A1∗28 and UGT1A1 -3156G>A. The pattern of observed allele frequencies for all polymorphisms could not be accurately estimated from any single previously studied population. Conclusion: This highlights the need to expand the scope of geographic data for use in pharmacogenomics studies.

AB - Background: Clinically relevant polymorphisms often demonstrate population-specific allele frequencies. Central and South America remain largely uncategorized in the context of pharmacogenomics. Materials & methods: We assessed 15 polymorphisms from 12 genes (ABCB1 3435C>T, ABCG2 Q141K, CYP1B1∗3, CYP2C19∗2, CYP3A4∗1B, CYP3A5∗3C, ERCC1 N118N, ERCC2 K751Q, GSTP1 I105V, TPMT 238G>C, TPMT 460G>A, TPMT 719A>G, TYMS TSER, UGT1A1∗28 and UGT1A1 -3156G>A) in 81 Peruvian and 95 Mexican individuals. Results: Six polymorphism frequencies differed significantly between the two populations: ABCB1 3435C>T, CYP1B1∗3, GSTP1 I105V, TPMT 460G>A, UGT1A1∗28 and UGT1A1 -3156G>A. The pattern of observed allele frequencies for all polymorphisms could not be accurately estimated from any single previously studied population. Conclusion: This highlights the need to expand the scope of geographic data for use in pharmacogenomics studies.

KW - Genotype

KW - Hispanic

KW - Mexico

KW - Peru

KW - Pharmacogenomics

KW - Polymorphism

KW - Population

UR - http://www.scopus.com/inward/record.url?scp=84929086164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929086164&partnerID=8YFLogxK

U2 - 10.2217/pgs.15.10

DO - 10.2217/pgs.15.10

M3 - Article

C2 - 25916516

AN - SCOPUS:84929086164

VL - 16

SP - 441

EP - 448

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 5

ER -